These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The role of GIP in α-cells and glucagon secretion. El K; Campbell JE Peptides; 2020 Mar; 125():170213. PubMed ID: 31785304 [TBL] [Abstract][Full Text] [Related]
7. Evaluating glucose-dependent insulinotropic polypeptide and glucagon as key regulators of insulin secretion in the pancreatic islet. Lewandowski SL; El K; Campbell JE Am J Physiol Endocrinol Metab; 2024 Jul; 327(1):E103-E110. PubMed ID: 38775725 [TBL] [Abstract][Full Text] [Related]
8. Effects on pancreatic Beta and other Islet cells of the glucose-dependent insulinotropic polypeptide. Khan R; Tomas A; Rutter GA Peptides; 2020 Mar; 125():170201. PubMed ID: 31751656 [TBL] [Abstract][Full Text] [Related]
9. TCF1 links GIPR signaling to the control of beta cell function and survival. Campbell JE; Ussher JR; Mulvihill EE; Kolic J; Baggio LL; Cao X; Liu Y; Lamont BJ; Morii T; Streutker CJ; Tamarina N; Philipson LH; Wrana JL; MacDonald PE; Drucker DJ Nat Med; 2016 Jan; 22(1):84-90. PubMed ID: 26642437 [TBL] [Abstract][Full Text] [Related]
10. Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1. Pathak V; Vasu S; Flatt PR; Irwin N Diabetes Obes Metab; 2014 Apr; 16(4):357-65. PubMed ID: 24164718 [TBL] [Abstract][Full Text] [Related]
11. Glucose intolerance and reduced proliferation of pancreatic beta-cells in transgenic pigs with impaired glucose-dependent insulinotropic polypeptide function. Renner S; Fehlings C; Herbach N; Hofmann A; von Waldthausen DC; Kessler B; Ulrichs K; Chodnevskaja I; Moskalenko V; Amselgruber W; Göke B; Pfeifer A; Wanke R; Wolf E Diabetes; 2010 May; 59(5):1228-38. PubMed ID: 20185813 [TBL] [Abstract][Full Text] [Related]
12. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877 [TBL] [Abstract][Full Text] [Related]
13. Spatiotemporal regulation of GIPR signaling impacts glucose homeostasis as revealed in studies of a common GIPR variant. Yammine L; Picatoste B; Abdullah N; Leahey RA; Johnson EF; Gómez-Banoy N; Rosselot C; Wen J; Hossain T; Goncalves MD; Lo JC; Garcia-Ocaña A; McGraw TE Mol Metab; 2023 Dec; 78():101831. PubMed ID: 37925022 [TBL] [Abstract][Full Text] [Related]
14. Chronic exposure to incretin metabolites GLP-1(9-36) and GIP(3-42) affect islet morphology and beta cell health in high fat fed mice. Sridhar A; Khan D; Babu G; Irwin N; Gault VA; Flatt PR; Moffett CR Peptides; 2024 Aug; 178():171254. PubMed ID: 38815655 [TBL] [Abstract][Full Text] [Related]
15. Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15. Puddu A; Sanguineti R; Montecucco F; Viviani GL J Diabetes Res; 2015; 2015():326359. PubMed ID: 26221611 [TBL] [Abstract][Full Text] [Related]
16. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes. Regazzo D; Barbot M; Scaroni C; Albiger N; Occhi G Rev Endocr Metab Disord; 2020 Mar; 21(1):165-183. PubMed ID: 31933128 [TBL] [Abstract][Full Text] [Related]
17. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Shu L; Matveyenko AV; Kerr-Conte J; Cho JH; McIntosh CH; Maedler K Hum Mol Genet; 2009 Jul; 18(13):2388-99. PubMed ID: 19386626 [TBL] [Abstract][Full Text] [Related]
18. Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'. Skow MA; Bergmann NC; Knop FK Diabetes Obes Metab; 2016 Sep; 18(9):847-54. PubMed ID: 27160961 [TBL] [Abstract][Full Text] [Related]